+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

Hollow Fiber Filtration Market Forecast to 2033 - Product Thumbnail Image

Hollow Fiber Filtration Market Forecast to 2033

  • Report
  • October 2025
  • 150 Pages
  • Global
From
2025 Protein Synthesis Research Review - Product Thumbnail Image

2025 Protein Synthesis Research Review

  • Report
  • April 2026
  • 144 Pages
  • Global
From
Protein Expression: Global Markets - Product Thumbnail Image

Protein Expression: Global Markets

  • Report
  • November 2025
  • 157 Pages
  • Global
From
Analytical Standards Market Report 2026 - Product Thumbnail Image

Analytical Standards Market Report 2026

  • Report
  • January 2026
  • 250 Pages
  • Global
From
From
From
From
Biopharmaceutical Excipients Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biopharmaceutical Excipients Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Bioengineered Protein Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Bioengineered Protein Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Biologics Safety Testing Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biologics Safety Testing Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 189 Pages
  • Global
From
From
Biologics Testing Service Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biologics Testing Service Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more